August 6, 2020


Merck Animal Health acquires traceability solutions provider




Merck Animal Healthannounced August 5 the completion of its acquisition of IdentiGEN, a leading DNA-based animal traceability solutions provider for livestock and aquaculture from MML Growth Capital Partners Ireland.

IdentiGEN's technology combines a species' unique DNA (deoxyribonucleic acid) and data analytics to provide an evidence-based animal traceability solution, called DNA TraceBack®, to accurately and precisely trace beef, seafood, pork and poultry that is verifiable from farm-to-table.

Food producers, processors and retailers are looking for animal traceability solutions that provide full accountability, as well as greater transparency, quality and sustainability of food sources for consumers. The addition of specialised, digital technology within Merck'sportfolio of medicines, vaccines and services, is said to provide holistic solutions to help advance animal health and complements the company's existing identification and monitoring technology that delivers real-time, actionable data and insights to help improve animal management and health outcomes.

"Enhanced digital technology will play an increasingly important role in food traceability and food safety, providing customers critical information and actionable data to help ensure a sustainable supply of quality food to protect public health," said Rick DeLuca, president, Merck Animal Health. "We now will be able to provide end-to-end animal traceability solutions at industry scale to improve the health and safety of animals and ensure even greater transparency in our food supply."

DeLuca added, "The highly skilled employees at IdentiGEN, led by Ronan Loftus and Ciaran Meghen, exemplify our commitment to The Science of Healthier Animals®, and we look forward to collaborating with the team to leverage our scientific and technical capabilities and expertise to shape the future of animal health."